At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Research of Olfactory Neuroepithelial Tissue as a Potential Biomarker of Alzheimer Disease
In Brief
An observational study for Alzheimer Disease. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the olfactory neuroepithelium as a biomarker of Alzheimer disease. The early diagnosis of Alzheimer disease is of importance for obtaining better response to treatment, but recently reported biomarkers have some limitations. Olfactory neuroepithelium tissue which is accessible through office-based biopsy without difficulty is known to reflect brain pathology that confirms the diagnosis of Alzheimer disease. This study will help in the early detection and treatment of Alzheimer disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer Disease
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2013
First PostedMay 2014
Primary CompletionDec 2014
Study CompletionFeb 2015
TodayJul 2026
First PostedMay 2, 2014
Enrollment StartJan 1, 2013
Primary CompletionDec 1, 2014
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 12.2 years ago